Sign In
Buy CDXS
$2.72
+0.0300 (+1.12%)
At Close: Jun 03, 2026
Exchange Traded Concepts LLC Takes Position in Codexis, Inc. (NASDAQ:CDXS)
10:12am, Saturday, 25'th Jan 2020
Exchange Traded Concepts LLC acquired a new stake in shares of Codexis, Inc. (NASDAQ:CDXS) during the 4th quarter, HoldingsChannel.com reports. The firm acquired 4,045 shares of the biotechnology comp
Codexis, Inc. (NASDAQ:CDXS) Director Bernard J. Kelley Sells 2,500 Shares
11:32am, Thursday, 23'rd Jan 2020
Codexis, Inc. (NASDAQ:CDXS) Director Bernard J. Kelley sold 2,500 shares of the company’s stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $18.00, for
Insider Selling: Codexis, Inc. (NASDAQ:CDXS) Director Sells $186,800.00 in Stock
09:58am, Monday, 20'th Jan 2020
Codexis, Inc. (NASDAQ:CDXS) Director Thomas R. Baruch sold 10,000 shares of the stock in a transaction dated Wednesday, January 15th. The shares were sold at an average price of $18.68, for a total tr
Here’s Why We’re Not Too Worried About Codexis’s (NASDAQ:CDXS) Cash Burn Situation
01:09pm, Sunday, 19'th Jan 2020
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Codexis (NASDAQ:CDXS) Upgraded by BidaskClub to Buy
07:24am, Wednesday, 15'th Jan 2020
Codexis (NASDAQ:CDXS) was upgraded by BidaskClub from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday, BidAskClub reports. Several other bro
Codexis Attends Opening Ceremony for Porton’s Fermentation Pilot Lab in Chongqing
09:05pm, Monday, 13'th Jan 2020
Codexis, Inc. (CDXS) today announced that it has attended the official opening of Porton Pharma Solutions Ltd.’s (300363.SZ) fermentation pilot laboratory located in Porton’s Changshou site, achie
Codexis Attends Opening Ceremony for Porton’s Fermentation Pilot Lab in Chongqing
09:05pm, Monday, 13'th Jan 2020
CHONGQING, China, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS) today announced that it has attended the official opening of Porton...
BRIEF-Codexis And Nestl Health Science Sign Development Deal
12:27pm, Friday, 10'th Jan 2020
Codexis Inc:
Codexis, Inc. (CDXS), a leading protein engineering company and developer of novel biotherapeutics, and Nestlé Health Science, a globally recognized leader in the field of nutritional science, have s
REDWOOD CITY, Calif., Jan. 10, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company and developer of novel...
We're Not Very Worried About Codexis's (NASDAQ:CDXS) Cash Burn Rate
02:06pm, Wednesday, 01'st Jan 2020
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
The Daily Biotech Pulse: NewLink Genetics Licenses Ovarian Cancer Dug, Correvio Awaits FDA Verdict
12:24pm, Tuesday, 24'th Dec 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 23) 10X Genomics Inc (NASDAQ: TXG )(reacted to a rulin
The Daily Biotech Pulse: NewLink Genetics Licenses Ovarian Cancer Dug, Correvio Awaits FDA Verdict
12:00am, Tuesday, 24'th Dec 2019Codexis Announces License Agreement with Roche for Enzyme Used in Next Generation Sequencing
12:00pm, Monday, 23'rd Dec 2019
Codexis, Inc. (CDXS), a leading protein engineering company, announces a license agreement to provide Roche with Codexis’ EvoT4TM DNA ligase high-performance molecular diagnostic enzyme. This enzym
